RecruitingPhase 4NCT07221877
A Study to Evaluate the Effect of KarXT on Urological Safety
Sponsor: Bristol-Myers Squibb
Bellflower, CA · Garden Grove, CA · Orange, CA · +13 more sites
Schizophrenia clinical trials in Orange, CA
10 recruiting schizophrenia studies with a site in Orange, CA.
RecruitingPhase 3NCT07424404
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Anaheim, CA · Chino, CA · +53 more sites
RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Bellflower, CA · Cerritos, CA · Culver City, CA · +42 more sites
RecruitingPhase 2NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Sponsor: MapLight Therapeutics
Anaheim, CA · Long Beach, CA · Murrieta, CA · +34 more sites
RecruitingPhase not listedNCT07101094
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Sponsor: Bristol-Myers Squibb
Orange, CA · San Jose, CA · +18 more sites
RecruitingPhase 2NCT06540833
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Sponsor: Intra-Cellular Therapies, Inc.
Anaheim, CA · Los Alamitos, CA · Newport Beach, CA · +25 more sites
RecruitingPhase 3NCT07686263
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Anaheim, CA · Bellflower, CA · Chino, CA · +31 more sites
RecruitingPhase 3NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Anaheim, CA · Chino, CA · Long Beach, CA · +99 more sites
RecruitingPhase 4NCT07105111
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Sponsor: Neurocrine Biosciences
Chino, CA · Fresno, CA · Long Beach, CA · +16 more sites
RecruitingPhase 2NCT06502964
Study of ALTO-101 in Patients With Schizophrenia
Sponsor: Alto Neuroscience
Garden Grove, CA · Los Angeles, CA · Orange, CA · +11 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.